Board of Directors
Björn O. Nilsson
Chairman of the Board
Doctor of Science. Born 1956. Lives in Sollentuna, Sweden. Professor, CEO and Fellow of the Royal Swedish Academy of Engineering Sciences (IVA) during the period 2008-2017. Associate professor at the Royal Institute of Technology (KTH) in Stockholm. Member of the Board since 1999. Chairman of the Board since 2011. Chairman of the Remuneration Committee and member of the Audit Committee.
Other board appointments: Chairman of the Boards of the Swedish Foundation for Strategic Research, Swedish Young Academy Foundation, Swedish Athletic Association and Stockholm Science City. Member of the Boards of ÅF AB, European Institute of Innovation and Technology (EIT) and SwedNanoTech AB.
M.Sc. Molecular and functional biology. Born 1959 Lives in Lund, Sweden. Senior Research Engineer. Member of the Board since 2013.
Other board appointments: -
Shareholding: 20,850 (own and affiliated holdings)
M.Sc. in Aerospace Engineering and M.Sc. in Business Economics. Born 1976. Lives in the Netherlands. CEO of SkylineDx since 2013. He is also currently the CEO of Quorics, Managing Director at Exponential BV, and Fund Manager at Swanbridge Capital. Extensive board experience within life science in current and previous board roles at Agendia, Bioinvent (2013-2016), deVGen, Innate Pharma, and Octoplus. Member of the Board since 2017. Member of the Audit Committee.
Other board appointments: Chairman of the Board of DCPrime. Member of the Boards of Isobionics and VitalneXt.
Elin Jaensson Gyllenbäck
Ph.D. in Immunology. Born 1979. Lives in Lund, Sweden. Senior Research Scientist. Member of the Board since 2017.
Other board appointments: -
Bachelor of Medicine. Born 1949. Lives in Halmstad, Sweden. Consul of Luxembourg. Member of the Board since 2006. Chairman of the Audit Committee.
Other board appointments: Member of the Board of Gyttorp AB.
An van Es Johansson
M.D. Born 1960. Lives in Stockholm, Sweden. Vice President and Head of Medical Affairs at Swedish Orphan Biovitrum AB (Sobi). Previously different executive positions in Clinical Development, Medical Affairs, Business Development and Commercial within Sobi, Eli Lilly, Roche, Pharmacia & Upjohn and biotech companies in USA, the Netherlands, Switzerland and Sweden. Member of the BioInvent Board since 2016. Member of the Remuneration Committee.
Other board appointments: Member of the Board of AlzeCure.
CFA, Ph.D. Born 1968. Lives in Commugny, Switzerland. Venture partner Omega Funds. Former partner Private Equity Sectoral Asset Management. Researcher at University of Geneva. Research analyst at Pictet Bank. Member of the BioInvent Board since 2016. Member of the Remuneration Committee.
Other board appointments: Member of the Boards of Andrew Alliance, Etherna Immunotherapies, Immunic, LifeSpan, Sophia Genetics and Board observer of Anaconda Brain.
Master of Business Administration. Born 1970. Lives in Stockholm, Sweden. Was President and CEO of Medivir AB 2014-2017. More than 20 years of experience from executive and leading positions working both in Sweden and in the US for i.a. Merck & Co. Inc., Pfizer AB, Qbtech AB and Envirotainer AB. Member of the BioInvent Board since 2017. Member of the Audit commitee.
Other board appointments: Chairman of the Board of Fodi Skandinavien AB and Qbtech AB. Member of the Boards of Adero AB and CellaVision AB.